We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
MGUO | Magnum Mining and Exploration Ltd | 0.008 | 0.005 | 166.67% | 4,677,508 | 12 |
FRSOA | Forrestania Resources Ltd | 0.002 | 0.001 | 100.00% | 400,000 | 1 |
LPDOE | Lepidico Ltd | 0.002 | 0.001 | 100.00% | 500,000 | 1 |
BUR | Burley Minerals Ltd | 0.155 | 0.069 | 80.23% | 2,004,296 | 151 |
ERW | Errawarra Resources Ltd | 0.099 | 0.039 | 65.00% | 17,347,151 | 807 |
M4MOB | Macro Metals Ltd | 0.03 | 0.01 | 50.00% | 6,070,454 | 29 |
WHKO | WhiteHawk Limited | 0.003 | 0.001 | 50.00% | 1,927,961 | 10 |
LV1OA | Live Verdure Ltd | 0.30 | 0.10 | 50.00% | 243,607 | 10 |
SRNOD | Surefire Resources NL | 0.003 | 0.001 | 50.00% | 2,000,000 | 2 |
APC | Australian Potash Limited | 0.0015 | 0.0005 | 50.00% | 6,183,514 | 14 |
IND | Industrial Minerals Limited | 0.26 | 0.085 | 48.57% | 653,943 | 55 |
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a potential multi-billion dollar revenue opportunity for Novavax including:$500 million upfront payment Approximately $70 million equity investment in NovavaxUp to $700 million in COVID-19 and combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTMÂ adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza Combination vaccine trial, which is on-track to initiate second half of 2024, with potential ...
NEW YORK, May 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. (NASDAQ: VFS).
SINGAPORE, May 13, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) (the "Company"), a global leader in solar innovation and channels, today announced it will postpone the release of its Fourth Quarter, Fiscal Year 2023 and First Quarter 2024 Financial Results, previously scheduled for May 15, 2024 U.S. ET / May 16, Singapore Time, to May 23, 2024. The additional time is necessary to complete the Company's preparation of its annual and quarterly reports and to provide the market with a comprehensive business update.
- Vuzix will offer select clients a private look at its next generation optics system technologies designed specifically for fashion forward smart glasses ROCHESTER, N.Y., May 10, 2024 /PRNewswire/ -- – Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, announced it will be offering, by-request-only, demonstrations of its latest optical display system advancements at Display Week 2024, May 12-17 in San Jose, California. As a leading industry supplier of integrated AR solutions, Vuzix has set the bar for what's possible with enterprise and consumer waveguide-enabled wearable displays, having brought ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,166.61 | 1,718.62 | 2.80% | 1.24T | 3,265,851,646 |
ETH | Ethereum | 2,965.69 | 38.19 | 1.30% | 355.23B | 1,646,735,517 |
USDT | Tether USD | 0.9998 | 0.00031 | 0.03% | 97.82B | 105,992,675 |
BNB | Binance Coin | 595.78 | 2.07 | 0.35% | 94.03B | 304,321,988 |
SOL | Solana | 148.52 | 4.22 | 2.92% | 65.04B | 854,457,633 |
STETH | stETH | 2,966.31 | 40.56 | 1.39% | 28.99B | 3,418,021 |
USDC | USD Coin | 1.00 | 0.00002 | 0.00% | 28.07B | 453,335,683 |
XRP | Ripple | 0.5109 | 0.01136 | 2.27% | 27.81B | 253,247,556 |
TONCOIN | Wrapped TON Coin | 7.25 | 0.284564 | 4.09% | 25.05B | 431,784,884 |
DOGE | Dogecoin | 0.15481 | 0.01231 | 8.64% | 22.03B | 331,940,100 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions